Mu-Opioid Receptor Antagonist Market to Reach a Market Value of US$4.8 Billion by 2023
The global opioid induced constipation treatment market is highly consolidated with the presence of few companies. The top three companies, namely Takeda Pharmaceutical Company Ltd, Valeant Pharmaceuticals International Ltd, and Boehringer Ingelheim, dominate the global opioid induced constipation treatment market.
View full press release